Rheumatology - Clinical trials - Mayo Clinic

COVID-19 Advice updates and vaccine options

Find out about COVID-19, COVID-19 vaccines, and Mayo Clinic patient and visitor updates. Skip to site navigation Skip to Content This content does not have an English version.This content does not have an Arabic version. Search Request an Appointment Find a Doctor Find a Job Give Now Log in to Patient Account English Español العربية 简体中文 Twitter Facebook Pinterest YouTube Menu Request an Appointment Departments & Centers Medical Departments & Centers

Rheumatology

Clinical trials

Below are current clinical trials.
13 studies in Rheumatology
(open studies only). Filter this list of studies by location, status and more.

A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis

Rochester, Minn. The primary purpose of this study is to describe the utilization and findings on magnetic resonance imaging (MRI) of the hands and feet in patients with seronegative rheumatoid arthritis (RA) (based on the ACR 1987 or 2010 classification criteria) compared to the findings seen in patients with seropositive disease (RF or ACPA positive).

A Study to Enroll Patients of Rheumatic Diseases and First-degree Relatives in a Biobank

Rochester, Minn. The purpose of this study is to enroll rheumatic disease patients and first-degree relatives in a biobank, and to follow them over time to assess health outcomes and collect additional specimens.

Exploring the Role of B-cell Activating Factor Receptor BAFFR -based Chimeric Antigen Receptor T-cell CAR T in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large B-cell, mantle cell and follicular lymphoma, chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to explore the therapeutic efficacy of BAFFR-CAR T cells in autoimmune rheumatologic diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models.

A Study to to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making

Rochester, Minn. The primary objective of this study is to determine the impact of ArthritisPower integration into the clinical evaluation of patients with RA on the primary endpoint of clinical improvement as defined by the continuous change in the Clinical Disease Activity Index.

Daratumumab to Treat Active Lupus Nephritis

Rochester, Minn. The purpose of this study is to assess the effectiveness and safety of daratumumab in inducing complete or partial remission in patients with active class III or IV (± V) lupus nephritis (LN) as measured by change in proteinuria and serum creatinine.

The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

Rochester, Minn. This study is a multi-center randomized controlled trial to evaluate the effects of using low-dose prednisone as compared to stopping prednisone treatment entirely. Participants will be randomized 1:1 to taper their prednisone dose down to 5 mg/day or to 0 mg/day for the duration of the study (approximately six months) or until a study endpoint.

The ANSWERS Study

Rochester, Minn. The purpose of this study is to better understand Antiphospholipid syndrome (APS) pathophysiology and to aid development of targeted therapeutics.

A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis

Rochester, Minn. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the quantitative CT (Q-CT) tool CALIPER is a novel measure that can be used for the early detection of pulmonary vascular remodeling in patients with SSc. pulmonary related vascular structures

MEPOLIZUMAB FOR THE TREATMENT OF EOSINOPHILIC FASCIITIS AN OPEN-LABEL SINGLE-ARM EXPLORATORY STUDY

Jacksonville, Fla. The purpose of this study is to investigate the efficacy of mepolizumab in the treatment of eosinophilic fasciitis.

Biomarkers in Autoimmune and Inflammatory Diseases

Rochester, Minn. The purpose of this study is to identify biomarkers in people with autoimmune or inflammatory disease and in healthy people. We will use these biomarkers to develop tests that will help us better understand the same biomarkers in the blood of people who have autoimmune and inflammatory diseases. Request an Appointment at Mayo Clinic Locations, travel & lodgingResearch April 01, 2020 Share on: FacebookTwitter

Rheumatology

SectionsOverviewTests & proceduresConditions treatedDoctorsSpecialty groupsExpertise & rankingsLocations, travel & lodgingClinical trialsResearchThe Mayo Clinic experience & patient storiesCosts & insuranceNews from Mayo ClinicReferrals

Research It s All About Patients

Sections

Request an AppointmentOverviewTests & proceduresConditions treatedDoctorsSpecialty groupsExpertise & rankingsLocations, travel & lodgingClinical trialsResearchThe Mayo Clinic experience & patient storiesCosts & insuranceNews from Mayo ClinicReferrals ORG-20476802 Departments & Centers Medical Departments & Centers Rheumatology